T-cell prolymphocytic leukemia, a case report and review of the literature
Luis Manuel GONZáLEZ-RODRíGUEZ, Javier Loscertales, Eva Arranz, Jimena Cannata‐Ortiz et autres
mutation. Here, we aim to review the genetic and molecular underpinnings of T-prolymphocytic leukemia, as well as current treatment options, with a focus on the anti-CD52 monoclonal antibody alemtuzumab and JAK inhibitors. While alemtuzumab followed by allogeneic hematopoietic stem cell transplantation remains …
es, us (code pays fourni par la source)
2 citations
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics